Puma Biotechnology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Puma Biotechnology Inc 's Inventory turnover ratio has remained unchanged compare to previous quarter at 7.19 in the first quarter 2026Average processing period, for Puma Biotechnology Inc 's inventories remained unchanged at 51 days, in the Mar 31 2026 quarter.

Within Healthcare sector 53 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 319 in the fourth quarter 2025, to 358.

PBYI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Puma Biotechnology Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PBYI Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-0.66 %	-36.78 %	254.51 %	-5.06 %	23.25 %
Y / Y Cost of Sales Growth	-1.25 %	66.13 %	-58.16 %	15.42 %	-1.6 %
Inventory Turnover Ratio (TTM)	7.19	7.19	5.51	9.17	8.8
PBYI's Total Ranking	# 358	# 319	# 398	# 327	# 281
Average inventory processing period	51	51	66	40	41
Seq. Inventory Growth	57.62 %	-41.8 %	10.3 %	-1.83 %	0.31 %
Seq. Cost of Sales Growth	-54.93 %	89.99 %	-1.04 %	16.53 %	-24.17 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 9
Healthcare Sector	# 54
Overall Market	# 358

Inventory Turnover Ratio Statistics
High	Average	Low
13.89	10.2	5.51
(Mar 31 2021)		(Sep 30 2025)

PBYI Company Profile >> Back to PBYI Efficiency Comparisons >> Compare PBYI Inventory Turnover Ratio to its Competitors

Financial Statements
Puma Biotechnology Inc 's Inventories	$ 9 Millions	Visit PBYI's Balance sheet
Puma Biotechnology Inc 's Cost of Revenues TTM	$ 58 Millions	Visit PBYI's Income Statement
What are PBYI's Sales?		Visit PBYI's Sales by Segment

Other Inventory Turnover Ratios
Puma Biotechnology Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PBYI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PBYI's Competitors
Inventory Turnover Ratio for PBYI's Suppliers
Inventory Turnover Ratio for PBYI's Customers

You may also want to know
PBYI's Sales Growth Rates	PBYI's Pe Price to earnings ratio	PBYI's Receivables Turnover Ratio	PBYI's Stock Quote
PBYI's Net Income Growth Rates	PBYI's Ps Price to Sales ratio	PBYI's Sales per Employee	PBYI's Asset Turnover Ratio
PBYI's Net Margin	PBYI's Pb Price to Book ratio	PBYI's Financial Strength Ratios	PBYI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Lucid Diagnostics Inc	18.30	$ 8.295 Millions	$ 0 Millions
Adapthealth Corp	17.66	$ 2,686.512 Millions	$ 152 Millions
Neuronetics Inc	17.04	$ 78.000 Millions	$ 5 Millions
Precipio inc	15.93	$ 14.540 Millions	$ 1 Millions
Rockwell Medical inc	15.34	$ 56.000 Millions	$ 4 Millions
Star Equity Holdings Inc	14.45	$ 112.008 Millions	$ 8 Millions
Aurinia Pharmaceuticals Inc	14.12	$ 30.596 Millions	$ 2 Millions
Natera Inc	13.48	$ 869.958 Millions	$ 65 Millions
Cryo cell International Inc	13.44	$ 7.049 Millions	$ 1 Millions
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions

Date modified: 2026-08-29T17:19:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.